119 related articles for article (PubMed ID: 38745208)
1. Mutational landscape of HSP family on human breast cancer.
Fernandez-Muñoz JM; Guerrero-Gimenez ME; Ciocca LA; Germanó MJ; Zoppino FCM
Sci Rep; 2024 May; 14(1):12471. PubMed ID: 38816397
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer proteogenomics characterization of tumor immunity.
Petralia F; Ma W; Yaron TM; Caruso FP; Tignor N; Wang JM; Charytonowicz D; Johnson JL; Huntsman EM; Marino GB; Calinawan A; Evangelista JE; Selvan ME; Chowdhury S; Rykunov D; Krek A; Song X; Turhan B; Christianson KE; Lewis DA; Deng EZ; Clarke DJB; Whiteaker JR; Kennedy JJ; Zhao L; Segura RL; Batra H; Raso MG; Parra ER; Soundararajan R; Tang X; Li Y; Yi X; Satpathy S; Wang Y; Wiznerowicz M; González-Robles TJ; Iavarone A; Gosline SJC; Reva B; Robles AI; Nesvizhskii AI; Mani DR; Gillette MA; Klein RJ; Cieslik M; Zhang B; Paulovich AG; Sebra R; Gümüş ZH; Hostetter G; Fenyö D; Omenn GS; Cantley LC; Ma'ayan A; Lazar AJ; Ceccarelli M; Wang P;
Cell; 2024 Feb; 187(5):1255-1277.e27. PubMed ID: 38359819
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes.
Sharma A; Debik J; Naume B; Ohnstad HO; ; Bathen TF; Giskeødegård GF
Oncogenesis; 2024 Jun; 13(1):22. PubMed ID: 38871719
[TBL] [Abstract][Full Text] [Related]
4. Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection.
Raj-Kumar PK; Lin X; Liu T; Sturtz LA; Gritsenko MA; Petyuk VA; Sagendorf TJ; Deyarmin B; Liu J; Praveen-Kumar A; Wang G; McDermott JE; Shukla AK; Moore RJ; Monroe ME; Webb-Robertson BM; Hooke JA; Fantacone-Campbell L; Mostoller B; Kvecher L; Kane J; Melley J; Somiari S; Soon-Shiong P; Smith RD; Mural RJ; Rodland KD; Shriver CD; Kovatich AJ; Hu H
Breast Cancer Res; 2024 May; 26(1):76. PubMed ID: 38745208
[TBL] [Abstract][Full Text] [Related]
5. Low level of ARID1A contributes to adaptive immune resistance and sensitizes triple-negative breast cancer to immune checkpoint inhibitors.
Chen XY; Li B; Wang Y; Jin J; Yang Y; Huang LH; Yang MD; Zhang J; Wang BY; Shao ZM; Ni T; Huang SL; Hu XC; Tao ZH
Cancer Commun (Lond); 2023 Sep; 43(9):1003-1026. PubMed ID: 37434394
[TBL] [Abstract][Full Text] [Related]
6. RBM14 as a novel epigenetic-activated tumor oncogene is implicated in the reprogramming of glycolysis in lung cancer.
Hu Y; Mu H; Deng Z
World J Surg Oncol; 2023 Apr; 21(1):132. PubMed ID: 37060064
[TBL] [Abstract][Full Text] [Related]
7. Utilizing an Endogenous Progesterone Receptor Reporter Gene for Drug Screening and Mechanistic Study in Endometrial Cancer.
Li Y; Zhou W; Meng X; Murray SD; Li L; Fronk A; Lazaro-Camp VJ; Wen KK; Wu M; Dupuy A; Leslie KK; Yang S
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230806
[TBL] [Abstract][Full Text] [Related]
8. Experimental reproducibility limits the correlation between mRNA and protein abundances in tumor proteomic profiles.
Upadhya SR; Ryan CJ
Cell Rep Methods; 2022 Sep; 2(9):100288. PubMed ID: 36160043
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in therapeutic strategies for triple-negative breast cancer.
Li Y; Zhang H; Merkher Y; Chen L; Liu N; Leonov S; Chen Y
J Hematol Oncol; 2022 Aug; 15(1):121. PubMed ID: 36038913
[TBL] [Abstract][Full Text] [Related]
10. Glycoproteomics Identifies Plexin-B3 as a Targetable Cell Surface Protein Required for the Growth and Invasion of Triple-Negative Breast Cancer Cells.
Kuhlmann L; Govindarajan M; Mejia-Guerrero S; Ignatchenko V; Liu LY; Grünwald BT; Cruickshank J; Berman H; Khokha R; Kislinger T
J Proteome Res; 2022 Sep; 21(9):2224-2236. PubMed ID: 35981243
[TBL] [Abstract][Full Text] [Related]
11. Cancer proteogenomics: current impact and future prospects.
Mani DR; Krug K; Zhang B; Satpathy S; Clauser KR; Ding L; Ellis M; Gillette MA; Carr SA
Nat Rev Cancer; 2022 May; 22(5):298-313. PubMed ID: 35236940
[TBL] [Abstract][Full Text] [Related]
12. Emerging Role of E2F Family in Cancer Stem Cells.
Xie D; Pei Q; Li J; Wan X; Ye T
Front Oncol; 2021; 11():723137. PubMed ID: 34476219
[TBL] [Abstract][Full Text] [Related]
13. ZC3HAV1 promotes the proliferation and metastasis via regulating KRAS in pancreatic cancer.
Huang W; Hua H; Xiao G; Yang X; Yang Q; Jin L
Aging (Albany NY); 2021 Jul; 13(14):18482-18497. PubMed ID: 34319912
[TBL] [Abstract][Full Text] [Related]
14. Aberrations of Chromosomes 1 and 16 in Breast Cancer: A Framework for Cooperation of Transcriptionally Dysregulated Genes.
Privitera AP; Barresi V; Condorelli DF
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33808143
[TBL] [Abstract][Full Text] [Related]
15. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
16. Abnormal Expression of Mitochondrial Ribosomal Proteins and Their Encoding Genes with Cell Apoptosis and Diseases.
Huang G; Li H; Zhang H
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238645
[TBL] [Abstract][Full Text] [Related]
17. Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.
Krug K; Jaehnig EJ; Satpathy S; Blumenberg L; Karpova A; Anurag M; Miles G; Mertins P; Geffen Y; Tang LC; Heiman DI; Cao S; Maruvka YE; Lei JT; Huang C; Kothadia RB; Colaprico A; Birger C; Wang J; Dou Y; Wen B; Shi Z; Liao Y; Wiznerowicz M; Wyczalkowski MA; Chen XS; Kennedy JJ; Paulovich AG; Thiagarajan M; Kinsinger CR; Hiltke T; Boja ES; Mesri M; Robles AI; Rodriguez H; Westbrook TF; Ding L; Getz G; Clauser KR; Fenyö D; Ruggles KV; Zhang B; Mani DR; Carr SA; Ellis MJ; Gillette MA;
Cell; 2020 Nov; 183(5):1436-1456.e31. PubMed ID: 33212010
[TBL] [Abstract][Full Text] [Related]
18.
Zhang Y; Parmigiani G; Johnson WE
NAR Genom Bioinform; 2020 Sep; 2(3):lqaa078. PubMed ID: 33015620
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
